Cytotoxic depsipeptides

Details for Australian Patent Application No. 2004251103 (hide)

Owner Instituto Biomar S.A.

Inventors Malet, Leyre; Romero, Paco; Cuevas, Carmen; Canedo, Librada Maria; Fernando Reyes, Jose

Agent Griffith Hack

Pub. Number AU-A-2004251103

PCT Pub. Number WO2005/000880

Priority 0314726.1 24.06.03 GB

Filing date 23 June 2004

Wipo publication date 6 January 2005

International Classifications

C07K 5/097 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/06 (2006.01) Medicinal preparations containing peptides - Tripeptides

A61P 35/00 (2006.01) Antineoplastic agents

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

C12R 1/04 (2006.01)

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000880 Priority application(s): WO2005/000880

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251104-N-{'4-substituted piperazine1-sulfonylmethyl!alkyl}-N-hydroxyfoma mide compounds as metalloproteinase inhibitors

2004251099-Biologically active peptide comprising tyrosyl-seryl-valine (YSV)